Noida, India – 17th February, 2017 – HCL Technologies (HCL), a leading global IT services provider, continues to be recognized for its global leadership in life sciences IT services and solutions. Everest Group, in its report "Life Sciences IT Application Services – Service Provider Landscape with PEAK MatrixTM Assessment 2016” named HCL among leaders, recognizing HCL’s ‘wide range of application services solutions across all value chain elements of life sciences practice.’
The Everest report analysed the capabilities of 22 IT application services providers specific to the global life sciences sectors and mapped them on the Everest Group Performance| Experience |Ability |Knowledge (PEAK) Matrix, which is a composite index of a range of distinct metrics related to a provider's capability and market success.
“Life Sciences industry is making a significant shift in its approach to adoption of technology, especially applications. Time-to-value (getting viable products faster to market) and business growth are key metrics that are determining sourcing constructs. HCL Technologies has shown good traction in aligning its go to market to these enterprise objectives,” said Abhishek Singh, Practice Director and Leader of Healthcare & Life Sciences research, Everest Group
“HCL has been recognized for its global leadership, strengths of solutions and problem solving ability across the entire life sciences value chain – clinical & R&D, manufacturing operations, sales & marketing and supply chain & distribution,” said Abhishek Shankar, Vice President – Life Sciences and Healthcare, HCL Technologies. “HCL segments the market across biopharma, medical devices and the related adjacencies, and this recognition underscores HCL's unique approach in addressing industry challenges through the continuum of healthcare into life sciences.”
HCL’s life sciences & healthcare practice, one of the early movers in the space, offers transformational services for 21st Century Life–Sciences Enterprises’ success. The practice is one of the most mature among global IT services providers and has emerged as a partner of choice for leading global lifesciences, healthcare, pharmaceuticals and medical devices companies.
About HCL Technologies
HCL Technologies (HCL) is a leading global IT services company that helps global enterprises re–imagine and transform their businesses through Digital technology transformation. HCL operates out of 32 countries and has consolidated revenues of US$ 6.7 billion, for 12 months ended 31st December, 2016. HCL focuses on providing an integrated portfolio of services underlined by its Mode 1–2–3 growth strategy. Mode 1 encompasses the core services in the areas of Applications, Infrastructure, BPO and Engineering & R&D services, leveraging DRYiCETM Autonomics to transform clients' business and IT landscape, making them 'lean' and 'agile'. Mode 2 focuses on experience–centric and outcome–oriented services such as Digital and Analytics Services (BEYONDigitalTM), IoT WorKSTM, Cloud and Security, utilizing DRYiCETM Orchestration to drive business outcomes and enable enterprise digitalization. Mode 3 strategy is ecosystem–driven, creating innovative IP–partnerships to build products and platforms business.
HCL leverages its global network of integrated co-innovation labs, and global delivery capabilities to provide holistic multi–service delivery in key industry verticals including Financial Services, Manufacturing, Telecommunications, Media, Publishing, Entertainment, Retail CPG, Life Sciences Healthcare, Oil & Gas, Energy & Utilities, Travel, Transportation & Logistics and Government. With 111,092 professionals from diverse nationalities, HCL focuses on creating real value for customers by taking 'Relationships Beyond the Contract'. For more information, please visit www.hcltech.com
Certain statements in this release are forward-looking statements, which involve a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ materially from those in such forward-looking statements. All statements, other than statements of historical fact are statements that could be deemed forward-looking statements, including but not limited to the statements containing the words 'planned', 'expects', 'believes’,’ strategy', 'opportunity', 'anticipates', 'hopes' or other similar words. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding impact of pending regulatory proceedings, fluctuations in earnings, our ability to manage growth, intense competition in IT services, business process outsourcing and consulting services including those factors which may affect our cost advantage, wage increases in India, customer acceptances of our services, products and fee structures, our ability to attract and retain highly skilled professionals, our ability to integrate acquired assets in a cost-effective and timely manner, time and cost overruns on fixed-price, fixed-timeframe contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, the success of our brand development efforts, liability for damages on our service contracts, the success of the companies /entities in which we have made strategic investments, withdrawal of governmental fiscal incentives, political instability, legal restrictions on raising capital or acquiring companies outside India, and unauthorized use of our intellectual property, other risks, uncertainties and general economic conditions affecting our industry. There can be no assurance that the forward-looking statements made herein will prove to be accurate, and issuance of such forward-looking statements should not be regarded as a representation by the Company, or any other person, that the objective and plans of the Company will be achieved. All forward-looking statements made herein are based on information presently available to the Management of the Company and the Company does not undertake to update any forward-looking statement that may be made from time to time by or on behalf of the Company.
For details contact
Sumit Ranjan Aggarwal